ClinicalTrials.gov
public full text
Public Domain
INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections
To evaluate the safety and efficacy of red blood cells (RBCs) prepared with the INTERCEPT Blood System for Red Blood Cells Pathogen Reduction Treatment (PRT) in comparison to conventional RBCs in patients who require RBC transfusion support.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients#901193
- Factors That Contribute To Red Blood Cells Transfusion Among Obstetrics Patients In Hospital Serdang, Selangor#352719
- Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers#825155
- Investigation of the Transfusion Practices in Surgical Patients in Turkey#829032
- Effect of Preoperative Recombinant Human Erythropoietin on Transfusion Risk in Valvular Heart Surgery#908445
Record · ID 862415
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive